Difficulty: Medium
Average Score: 80%
Practice
Which of the following patients would likely be the most appropriate candidate for treatment with filgrastim (Neupogen)?
Correct answer
D
Rationale
Filgrastim treats neutropenia from chemotherapy or bone marrow transplantation, stimulating neutrophil recovery to prevent infections. A leukemia patient post-transplant, with suppressed marrow, fits this profile, as immunosuppression risks severe neutropenia. Mastectomy, AIDS with sarcoma, or renal failure from rhabdomyolysis don't inherently involve such marrow compromise requiring filgrastim. Its use here accelerates immune reconstitution, critical for survival, aligning with its indication in marrow-suppressing contexts over other conditions lacking this specific need.